IMMUNE PRIMING WITH NIVOLUMAB FOLLOWED BY NIVOLUMAB & RITUXIMAB IN 1 ST LINE TREATMENT OF FOLLICULAR LYMPHOMA: THE PHASE 2 1 ST FLOR STUDY

Authors :: S. T. Lee
Rishu Agarwal
Kate Manos
David Ritchie
Colm Keane
C. Smith
Eliza A Hawkes
K. Houdyk
Allison Barraclough
Rachel Koldej
G. Chong
Andrew Grigg
T. Fancourt
Leonid Churilov
Michael Gilbertson
J. Hawking
Source :: Hematological Oncology. 39
Publication Year :: 2021
Publisher :: Wiley, 2021.

Tools